Cardiovascular diseases are the leading cause of morbidity and mortality among patients with diabetes mellitus and cause the largest direct and indirect costs of diabetes care. The effectiveness of the management of individual cardiovascular factors has been proven risk in the prevention of CVD in people with diabetes. Great benefits become apparent when multiple risk factors are addressed at the same time. It is recommended to systematically assess and control CV risk factors in all patients with diabetes at least once a year. These risk factors include obesity, dyslipidemia, hypertension, smoking, family history of early coronary artery disease, and albuminuria.
The relevance of prevention, early diagnosis and treatment of CVD in patients with diabetes is obvious, and therefore, in 2015, a department was organized at the RSNPMCE Cardiac diabetes
Main directions of the department's work:
The departments can receive a comprehensive examination and treatment of patients with diabetes mellitus and cardiovascular diseases: ischemic heart disease (stable angina pectoris, unstable angina pectoris, postinfarction cardiosclerosis), hypertension, heart failure, dyslipidemia.
Patients are examined in accordance with international standards: daily ECG monitoring using the Holter method, daily monitoring blood pressure, stress tests on treadmill, echocardiography, color uplex scanning of the vessels of the neck and lower extremities, diagnostics of cardiovascular neuropathies, assessment of renal function, study of the lipid spectrum of blood. Cardiologists are simultaneously involved in the treatment of patients.
Simultaneously with cardiotherapeutic treatment, patients with diabetes mellitus are diagnosed with diabetes complications, and the selection of antidiabetic therapy. The risk of an unfavorable outcome of ischemic heart disease in patients with diabetes is assessed and a timely differentiated approach to therapy is carried out.
Individual training is also provided for patients in the basics of self-control, diet and insulin therapy, blood pressure control
Department structure: 21-bed department (1-2 bed wards)
Hospitalization is inpatient. The average length of hospital stay is 10 days.